The Role of PI3K Inhibition in the Treatment of Breast Cancer, Alone or Combined With Immune Checkpoint Inhibitors

Overview of attention for article published in Frontiers in Molecular Biosciences, May 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

twitter: 2 X users

patent: 1 patent

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 67 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 5,173 followers.

The Ann Richmond lab published a review in @FrontiersIn MolecBiosci that talks about the dysregulation of PI3K signaling in tumorigenesis/disease progression/resistance development, plus the potential use of inhibitors + immunotherapy for breast cancers.

01 Jun 2021

Reply Repost Favourite

New Research: The Role of PI3K Inhibition in the Treatment of Breast Cancer, Alone or Combined With Immune Checkpoint Inhibitors https://t.co/gzOqTVL6am #MolBioSci

21 May 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.